[RNAZ] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
31-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -329.11%
YoY- -108.39%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 753 0 0 0 0 -
PBT -4,088 -5,134 -5,910 -802 -196 113.59%
Tax -0 13,275 2,924 369 -41 -
NP -4,088 -18,409 -8,834 -802 -196 113.59%
Tax Rate - - - - - -
Total Cost 4,841 18,409 8,834 802 196 122.80%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin -542.73 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -22.83 -1,134.84 -552.15 -100.46 -30.53 -7.00%
EPS Diluted -22.83 -1,134.84 -547.70 -100.46 -30.53 -7.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.